Correlation Between Endoscopic Findings And Helicobacter Pylori Infection In Chronic Kidney Disease Patients
1 other identifier
interventional
100
1 country
1
Brief Summary
The aim of this study is to
- 1.Evaluate frequency of H. pylori infection in patients with CKD.
- 2.Description the gastroduodenal lesions found in patients with chronic kidney disease and correlate it to H.pylori infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2023
CompletedStudy Start
First participant enrolled
July 1, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedJuly 3, 2023
June 1, 2023
5 months
May 12, 2023
June 25, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Description the gastroduodenal lesions found in upper endoscopy in patients with chronic kidney disease or not and correlate them to helicobacter pylori infection
up to 24 weeks
Study Arms (2)
patients with chronic kidney disease
ACTIVE COMPARATORpatients without chronic kidneys disease
ACTIVE COMPARATORInterventions
patients with upper gastrointestinal symptoms will gone to upper endoscopy and biopsy when indicated
Eligibility Criteria
You may qualify if:
- Patients with CKD classified as stages 3 to 5 according Kidney Disease Improving Global Outcomes classification, on hemodialysis or not.
- control group without chronic kidney disease.
You may not qualify if:
- frail patients with multiple comorbidities or malignant disease.
- pregnant ladies.
- patients recently on proton pump inhibitors two weeks or less prior to the interview.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag university hospital
Sohag, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Usama a arafa
Sohag University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
May 12, 2023
First Posted
July 3, 2023
Study Start
July 1, 2023
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
July 3, 2023
Record last verified: 2023-06